The effect of nitric oxide synthase inhibition with and without inhibition of prostaglandins on blood flow in different human skeletal ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-04-21

AUTHORS

Ilkka Heinonen, Bengt Saltin, Ylva Hellsten, Kari K. Kalliokoski

ABSTRACT

PurposeAnimal studies suggest that the inhibition of nitric oxide synthase (NOS) affects blood flow differently in different skeletal muscles according to their muscle fibre type composition (oxidative vs glycolytic). Quadriceps femoris (QF) muscle consists of four different muscle parts: vastus intermedius (VI), rectus femoris (RF), vastus medialis (VM), and vastus lateralis (VL) of which VI is located deep within the muscle group and is generally regarded to consist mostly of oxidative muscle fibres.MethodsWe studied the effect of NOS inhibition on blood flow in these four different muscles by positron emission tomography in eight young healthy men at rest and during one-leg dynamic exercise, with and without combined blockade with prostaglandins.ResultsAt rest blood flow in the VI (2.6 ± 1.1 ml/100 g/min) was significantly higher than in VL (1.9 ± 0.6 ml/100 g/min, p = 0.015) and RF (1.7 ± 0.6 ml/100 g/min, p = 0.0015), but comparable to VM (2.4 ± 1.1 ml/100 g/min). NOS inhibition alone or with prostaglandins reduced blood flow by almost 50% (p < 0.001), but decrements were similar in all four muscles (drug × muscle interaction, p = 0.43). During exercise blood flow was also the highest in VI (45.4 ± 5.5 ml/100 g/min) and higher compared to VL (35.0 ± 5.5 ml/100 g/min), RF (38.4 ± 7.4 ml/100 g/min), and VM (36.2 ± 6.8 ml/100 g/min). NOS inhibition alone did not reduce exercise hyperemia (p = 0.51), but combined NOS and prostaglandin inhibition reduced blood flow during exercise (p = 0.002), similarly in all muscles (drug × muscle interaction, p = 0.99).ConclusionNOS inhibition, with or without prostaglandins inhibition, affects blood flow similarly in different human QF muscles both at rest and during low-to-moderate intensity exercise. More... »

PAGES

1175-1180

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00421-017-3604-2

DOI

http://dx.doi.org/10.1007/s00421-017-3604-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085038290

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28432421


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1106", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Human Movement and Sports Science", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exercise", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Muscle, Skeletal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitric Oxide Synthase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostaglandin Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Regional Blood Flow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "omega-N-Methylarginine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Experimental Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5645.2", 
          "name": [
            "Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland", 
            "Department of Clinical Physiology and Nuclear Medicine, University of Turku, Turku, Finland", 
            "Division of Experimental Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heinonen", 
        "givenName": "Ilkka", 
        "id": "sg:person.01036617440.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036617440.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Copenhagen Muscle Research Center, University of Copenhagen, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.5254.6", 
          "name": [
            "Copenhagen Muscle Research Center, University of Copenhagen, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saltin", 
        "givenName": "Bengt", 
        "id": "sg:person.0626445044.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626445044.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Exercise and Sport Sciences, Section of Human Physiology, University of Copenhagen, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.5254.6", 
          "name": [
            "Exercise and Sport Sciences, Section of Human Physiology, University of Copenhagen, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hellsten", 
        "givenName": "Ylva", 
        "id": "sg:person.0731746535.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731746535.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kalliokoski", 
        "givenName": "Kari K.", 
        "id": "sg:person.01210110752.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210110752.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01003594", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027604973", 
          "https://doi.org/10.1007/bf01003594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1743-7075-10-43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019938111", 
          "https://doi.org/10.1186/1743-7075-10-43"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00421-012-2329-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009054106", 
          "https://doi.org/10.1007/s00421-012-2329-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-04-21", 
    "datePublishedReg": "2017-04-21", 
    "description": "PurposeAnimal studies suggest that the inhibition of nitric oxide synthase (NOS) affects blood flow differently in different skeletal muscles according to their muscle fibre type composition (oxidative vs glycolytic). Quadriceps femoris (QF) muscle consists of four different muscle parts: vastus intermedius (VI), rectus femoris (RF), vastus medialis (VM), and vastus lateralis (VL) of which VI is located deep within the muscle group and is generally regarded to consist mostly of oxidative muscle fibres.MethodsWe studied the effect of NOS inhibition on blood flow in these four different muscles by positron emission tomography in eight young healthy men at rest and during one-leg dynamic exercise, with and without combined blockade with prostaglandins.ResultsAt rest blood flow in the VI (2.6\u00a0\u00b1\u00a01.1\u00a0ml/100\u00a0g/min) was significantly higher than in VL (1.9\u00a0\u00b1\u00a00.6\u00a0ml/100\u00a0g/min, p\u00a0=\u00a00.015) and RF (1.7\u00a0\u00b1\u00a00.6\u00a0ml/100\u00a0g/min, p\u00a0=\u00a00.0015), but comparable to VM (2.4\u00a0\u00b1\u00a01.1\u00a0ml/100\u00a0g/min). NOS inhibition alone or with prostaglandins reduced blood flow by almost 50% (p\u00a0<\u00a00.001), but decrements were similar in all four muscles (drug\u00a0\u00d7\u00a0muscle interaction, p\u00a0=\u00a00.43). During exercise blood flow was also the highest in VI (45.4\u00a0\u00b1\u00a05.5\u00a0ml/100\u00a0g/min) and higher compared to VL (35.0\u00a0\u00b1\u00a05.5\u00a0ml/100\u00a0g/min), RF (38.4\u00a0\u00b1\u00a07.4\u00a0ml/100\u00a0g/min), and VM (36.2\u00a0\u00b1\u00a06.8\u00a0ml/100\u00a0g/min). NOS inhibition alone did not reduce exercise hyperemia (p\u00a0=\u00a00.51), but combined NOS and prostaglandin inhibition reduced blood flow during exercise (p\u00a0=\u00a00.002), similarly in all muscles (drug\u00a0\u00d7\u00a0muscle interaction, p\u00a0=\u00a00.99).ConclusionNOS inhibition, with or without prostaglandins inhibition, affects blood flow similarly in different human QF muscles both at rest and during low-to-moderate intensity exercise.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00421-017-3604-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1319730", 
        "issn": [
          "1439-6319", 
          "1432-1025"
        ], 
        "name": "European Journal of Applied Physiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "117"
      }
    ], 
    "keywords": [
      "nitric oxide synthase", 
      "blood flow", 
      "vastus medialis", 
      "NOS inhibition", 
      "rectus femoris", 
      "vastus lateralis", 
      "prostaglandin inhibition", 
      "vastus intermedius", 
      "nitric oxide synthase inhibition", 
      "exercise blood flow", 
      "oxide synthase inhibition", 
      "inhibition of prostaglandin", 
      "skeletal muscle", 
      "young healthy men", 
      "moderate intensity exercise", 
      "quadriceps femoris muscle", 
      "muscle fiber type composition", 
      "different muscle parts", 
      "positron emission tomography", 
      "rest blood flow", 
      "fiber type composition", 
      "human skeletal muscle", 
      "exercise hyperemia", 
      "healthy men", 
      "dynamic exercise", 
      "synthase inhibition", 
      "oxide synthase", 
      "oxidative muscle fibers", 
      "intensity exercise", 
      "different skeletal muscles", 
      "QF muscle", 
      "muscle groups", 
      "femoris muscle", 
      "emission tomography", 
      "muscle parts", 
      "prostaglandins", 
      "muscle", 
      "muscle fibers", 
      "different muscles", 
      "inhibition", 
      "exercise", 
      "type composition", 
      "different human skeletal muscles", 
      "hyperemia", 
      "blockade", 
      "MethodsWe", 
      "medialis", 
      "femoris", 
      "rest", 
      "lateralis", 
      "tomography", 
      "men", 
      "effect", 
      "decrement", 
      "synthase", 
      "intermedius", 
      "group", 
      "study", 
      "fibers", 
      "flow", 
      "part", 
      "composition", 
      "PurposeAnimal studies", 
      "one-leg dynamic exercise", 
      "ResultsAt rest blood flow", 
      "ConclusionNOS inhibition", 
      "different human QF muscles", 
      "human QF muscles"
    ], 
    "name": "The effect of nitric oxide synthase inhibition with and without inhibition of prostaglandins on blood flow in different human skeletal muscles", 
    "pagination": "1175-1180", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085038290"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00421-017-3604-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28432421"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00421-017-3604-2", 
      "https://app.dimensions.ai/details/publication/pub.1085038290"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_738.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00421-017-3604-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00421-017-3604-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00421-017-3604-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00421-017-3604-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00421-017-3604-2'


 

This table displays all metadata directly associated to this object as RDF triples.

217 TRIPLES      22 PREDICATES      108 URIs      96 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00421-017-3604-2 schema:about N04465756ddda4ad38519a4d7c6faed36
2 N0a7251c4d91542a291063189d5e6c91e
3 N0e95831a33d240bea5e2a44aa65bcc0e
4 N3954cd5896e24b5bb47ecf6caf991a8b
5 N4c4cf58e07cf4451aec9ec6314384527
6 N568805b3e677452bb10d7f5868217d70
7 N5b6ac8ce3f97401ea2626b091c2ac2e1
8 N89c80772f2ea404680f8c51c68daa867
9 Nbccb5ed2e2264002af89a488408bc51b
10 Nfa2e63e7fbac40f29d9a53935c5260bd
11 anzsrc-for:11
12 anzsrc-for:1106
13 anzsrc-for:1116
14 schema:author N3af7b84f3aa94d80abb6cfefdafe74ec
15 schema:citation sg:pub.10.1007/bf01003594
16 sg:pub.10.1007/s00421-012-2329-5
17 sg:pub.10.1186/1743-7075-10-43
18 schema:datePublished 2017-04-21
19 schema:datePublishedReg 2017-04-21
20 schema:description PurposeAnimal studies suggest that the inhibition of nitric oxide synthase (NOS) affects blood flow differently in different skeletal muscles according to their muscle fibre type composition (oxidative vs glycolytic). Quadriceps femoris (QF) muscle consists of four different muscle parts: vastus intermedius (VI), rectus femoris (RF), vastus medialis (VM), and vastus lateralis (VL) of which VI is located deep within the muscle group and is generally regarded to consist mostly of oxidative muscle fibres.MethodsWe studied the effect of NOS inhibition on blood flow in these four different muscles by positron emission tomography in eight young healthy men at rest and during one-leg dynamic exercise, with and without combined blockade with prostaglandins.ResultsAt rest blood flow in the VI (2.6 ± 1.1 ml/100 g/min) was significantly higher than in VL (1.9 ± 0.6 ml/100 g/min, p = 0.015) and RF (1.7 ± 0.6 ml/100 g/min, p = 0.0015), but comparable to VM (2.4 ± 1.1 ml/100 g/min). NOS inhibition alone or with prostaglandins reduced blood flow by almost 50% (p < 0.001), but decrements were similar in all four muscles (drug × muscle interaction, p = 0.43). During exercise blood flow was also the highest in VI (45.4 ± 5.5 ml/100 g/min) and higher compared to VL (35.0 ± 5.5 ml/100 g/min), RF (38.4 ± 7.4 ml/100 g/min), and VM (36.2 ± 6.8 ml/100 g/min). NOS inhibition alone did not reduce exercise hyperemia (p = 0.51), but combined NOS and prostaglandin inhibition reduced blood flow during exercise (p = 0.002), similarly in all muscles (drug × muscle interaction, p = 0.99).ConclusionNOS inhibition, with or without prostaglandins inhibition, affects blood flow similarly in different human QF muscles both at rest and during low-to-moderate intensity exercise.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N75816a2517324266939fa384ce84c7cb
25 Nfbc4b8db903d4d4dba1001bc9fe8ccb3
26 sg:journal.1319730
27 schema:keywords ConclusionNOS inhibition
28 MethodsWe
29 NOS inhibition
30 PurposeAnimal studies
31 QF muscle
32 ResultsAt rest blood flow
33 blockade
34 blood flow
35 composition
36 decrement
37 different human QF muscles
38 different human skeletal muscles
39 different muscle parts
40 different muscles
41 different skeletal muscles
42 dynamic exercise
43 effect
44 emission tomography
45 exercise
46 exercise blood flow
47 exercise hyperemia
48 femoris
49 femoris muscle
50 fiber type composition
51 fibers
52 flow
53 group
54 healthy men
55 human QF muscles
56 human skeletal muscle
57 hyperemia
58 inhibition
59 inhibition of prostaglandin
60 intensity exercise
61 intermedius
62 lateralis
63 medialis
64 men
65 moderate intensity exercise
66 muscle
67 muscle fiber type composition
68 muscle fibers
69 muscle groups
70 muscle parts
71 nitric oxide synthase
72 nitric oxide synthase inhibition
73 one-leg dynamic exercise
74 oxidative muscle fibers
75 oxide synthase
76 oxide synthase inhibition
77 part
78 positron emission tomography
79 prostaglandin inhibition
80 prostaglandins
81 quadriceps femoris muscle
82 rectus femoris
83 rest
84 rest blood flow
85 skeletal muscle
86 study
87 synthase
88 synthase inhibition
89 tomography
90 type composition
91 vastus intermedius
92 vastus lateralis
93 vastus medialis
94 young healthy men
95 schema:name The effect of nitric oxide synthase inhibition with and without inhibition of prostaglandins on blood flow in different human skeletal muscles
96 schema:pagination 1175-1180
97 schema:productId N7adc24ee9a2d4132a8aa2132453d3048
98 Na383abbdee6a43388aa85539fb51fb66
99 Nc4892cf0db1c4ffa8fe5747cb8a6dd45
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085038290
101 https://doi.org/10.1007/s00421-017-3604-2
102 schema:sdDatePublished 2021-11-01T18:30
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher Ne419d95a7d004070937f5d2854ffae4e
105 schema:url https://doi.org/10.1007/s00421-017-3604-2
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N04465756ddda4ad38519a4d7c6faed36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Prostaglandin Antagonists
111 rdf:type schema:DefinedTerm
112 N0a7251c4d91542a291063189d5e6c91e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Humans
114 rdf:type schema:DefinedTerm
115 N0e95831a33d240bea5e2a44aa65bcc0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Exercise
117 rdf:type schema:DefinedTerm
118 N30e205832a084ababd2c4488f21d04b4 rdf:first sg:person.0626445044.37
119 rdf:rest N4917f1a0da01409eb4de7751123acb7d
120 N3954cd5896e24b5bb47ecf6caf991a8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Enzyme Inhibitors
122 rdf:type schema:DefinedTerm
123 N3af7b84f3aa94d80abb6cfefdafe74ec rdf:first sg:person.01036617440.17
124 rdf:rest N30e205832a084ababd2c4488f21d04b4
125 N4917f1a0da01409eb4de7751123acb7d rdf:first sg:person.0731746535.38
126 rdf:rest N5eba1b97a1fb4aaa809640259175a7ab
127 N4c4cf58e07cf4451aec9ec6314384527 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name omega-N-Methylarginine
129 rdf:type schema:DefinedTerm
130 N568805b3e677452bb10d7f5868217d70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Adult
132 rdf:type schema:DefinedTerm
133 N5b6ac8ce3f97401ea2626b091c2ac2e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Nitric Oxide Synthase
135 rdf:type schema:DefinedTerm
136 N5eba1b97a1fb4aaa809640259175a7ab rdf:first sg:person.01210110752.34
137 rdf:rest rdf:nil
138 N75816a2517324266939fa384ce84c7cb schema:issueNumber 6
139 rdf:type schema:PublicationIssue
140 N7adc24ee9a2d4132a8aa2132453d3048 schema:name pubmed_id
141 schema:value 28432421
142 rdf:type schema:PropertyValue
143 N89c80772f2ea404680f8c51c68daa867 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Muscle, Skeletal
145 rdf:type schema:DefinedTerm
146 Na383abbdee6a43388aa85539fb51fb66 schema:name dimensions_id
147 schema:value pub.1085038290
148 rdf:type schema:PropertyValue
149 Nbccb5ed2e2264002af89a488408bc51b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Regional Blood Flow
151 rdf:type schema:DefinedTerm
152 Nc4892cf0db1c4ffa8fe5747cb8a6dd45 schema:name doi
153 schema:value 10.1007/s00421-017-3604-2
154 rdf:type schema:PropertyValue
155 Ne419d95a7d004070937f5d2854ffae4e schema:name Springer Nature - SN SciGraph project
156 rdf:type schema:Organization
157 Nfa2e63e7fbac40f29d9a53935c5260bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Male
159 rdf:type schema:DefinedTerm
160 Nfbc4b8db903d4d4dba1001bc9fe8ccb3 schema:volumeNumber 117
161 rdf:type schema:PublicationVolume
162 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
163 schema:name Medical and Health Sciences
164 rdf:type schema:DefinedTerm
165 anzsrc-for:1106 schema:inDefinedTermSet anzsrc-for:
166 schema:name Human Movement and Sports Science
167 rdf:type schema:DefinedTerm
168 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical Physiology
170 rdf:type schema:DefinedTerm
171 sg:journal.1319730 schema:issn 1432-1025
172 1439-6319
173 schema:name European Journal of Applied Physiology
174 schema:publisher Springer Nature
175 rdf:type schema:Periodical
176 sg:person.01036617440.17 schema:affiliation grid-institutes:grid.5645.2
177 schema:familyName Heinonen
178 schema:givenName Ilkka
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036617440.17
180 rdf:type schema:Person
181 sg:person.01210110752.34 schema:affiliation grid-institutes:grid.470895.7
182 schema:familyName Kalliokoski
183 schema:givenName Kari K.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210110752.34
185 rdf:type schema:Person
186 sg:person.0626445044.37 schema:affiliation grid-institutes:grid.5254.6
187 schema:familyName Saltin
188 schema:givenName Bengt
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626445044.37
190 rdf:type schema:Person
191 sg:person.0731746535.38 schema:affiliation grid-institutes:grid.5254.6
192 schema:familyName Hellsten
193 schema:givenName Ylva
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731746535.38
195 rdf:type schema:Person
196 sg:pub.10.1007/bf01003594 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027604973
197 https://doi.org/10.1007/bf01003594
198 rdf:type schema:CreativeWork
199 sg:pub.10.1007/s00421-012-2329-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009054106
200 https://doi.org/10.1007/s00421-012-2329-5
201 rdf:type schema:CreativeWork
202 sg:pub.10.1186/1743-7075-10-43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019938111
203 https://doi.org/10.1186/1743-7075-10-43
204 rdf:type schema:CreativeWork
205 grid-institutes:grid.470895.7 schema:alternateName Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland
206 schema:name Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland
207 rdf:type schema:Organization
208 grid-institutes:grid.5254.6 schema:alternateName Copenhagen Muscle Research Center, University of Copenhagen, Copenhagen, Denmark
209 Exercise and Sport Sciences, Section of Human Physiology, University of Copenhagen, Copenhagen, Denmark
210 schema:name Copenhagen Muscle Research Center, University of Copenhagen, Copenhagen, Denmark
211 Exercise and Sport Sciences, Section of Human Physiology, University of Copenhagen, Copenhagen, Denmark
212 rdf:type schema:Organization
213 grid-institutes:grid.5645.2 schema:alternateName Division of Experimental Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
214 schema:name Department of Clinical Physiology and Nuclear Medicine, University of Turku, Turku, Finland
215 Division of Experimental Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
216 Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland
217 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...